Cargando…
Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer
SIMPLE SUMMARY: Patients with platinum-resistant ovarian cancer experience poor prognosis. No mature evidence supports the routine adoption of immunotherapy alone in this setting. However, the combination of immunotherapy with target therapies seems to be a promising option in patients with ovarian...
Autores principales: | Indini, Alice, Nigro, Olga, Lengyel, Csongor György, Ghidini, Michele, Petrillo, Angelica, Lopez, Salvatore, Raspagliesi, Francesco, Trapani, Dario, Khakoo, Shelize, Bogani, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037571/ https://www.ncbi.nlm.nih.gov/pubmed/33916221 http://dx.doi.org/10.3390/cancers13071663 |
Ejemplares similares
-
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches
por: Ghidini, Michele, et al.
Publicado: (2021) -
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
por: Ghidini, Michele, et al.
Publicado: (2019) -
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
por: Khakoo, Shelize, et al.
Publicado: (2021) -
Fertility-sparing surgery in high-risk ovarian cancer
por: Ditto, Antonino, et al.
Publicado: (2015) -
Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?
por: Bogani, Giorgio, et al.
Publicado: (2019)